The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Hydroxychloroquine in lupus pregnancy
Abstract
Objective: Hydroxychloroquine (HCQ) is often needed to manage disease activity in systemic lupus erythematosus (SLE) during pregnancy. The purpose of this study was to examine lupus activity and pregnancy outcomes in women with SLE treated or not treated with HCQ during pregnancy. Methods: This was a prospective study of pregnancies in women with SLE who were evaluated between 1987 and 2002. The pregnancies were divided into 3 groups: no HCQ exposure during pregnancy (163 pregnancies), continuous use of HCQ during pregnancy (56 pregnancies), or cessation of HCQ treatment either in the 3 months prior to or during the first trimester of pregnancy (38 pregnancies). The pregnancy outcomes, fetal outcomes, and lupus activity during pregnancy were compared among these groups. Results: The rates of miscarriage, stillbirth, pregnancy loss, and congenital abnormality were not statistically different among the 3 groups. The degree of lupus activity during pregnancy, however, was significantly higher in women who stopped taking HCQ. These women had a higher degree of lupus activity, as measured by the physician's estimate of lupus activity and the SLE Disease Activity Index, as well as an increased rate of flare, during pregnancy. More serious lupus complications, such as proteinuria and thrombocytopenia, were not significantly higher in women who stopped taking HCQ. Women who continued taking HCQ were maintained on a lower average dose of prednisone during pregnancy. Conclusion: We recommend the continuation of HCQ treatment during pregnancy. Our findings are consistent with prior reports of the absence of fetal toxicity. Similar to studies of nonpregnant women, the cessation of HCQ treatment during pregnancy increases the degree of lupus activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
A united states national reference for fetal growth
ALEXANDER, G., HIMES, J., KAUFMAN, R., MOR, J., & KOGAN, M. (1996) · Obstetrics & Gynecology · doi:10.1016/0029-7844(95)00386-x · Cited by 2,294
Park-Wyllie, L., Mazzotta, P., Pastuszak, A., Moretti, M. E., Beique, L., Hunnisett, L., Friesen, M. H., Jacobson, S., Kasapinovic, S., Chang, D., et al. (2000) · Teratology · doi:10.1002/1096-9926(200012)62:6<385::aid-tera5>3.0.co;2-z · Cited by 955
(1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240303 · Cited by 677
Anti-inflammatory and immunosuppressive drugs and reproduction
Østensen, M., Khamashta, M. A., Lockshin, M. D., Parke, A. L., Brucato, A. L., Carp, H., Doria, A., Rai, R., Meroni, P. L., Cetin, I., et al. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1957 · Cited by 550
Self-citationThe impact of increased lupus activity on obstetric outcomes
Clowse, M. E. B., Magder, L. S., Witter, F., & Petri, M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20864 · Cited by 428
Self-citationHydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study
Levy, R. A., Vilela, V. S., Cataldo, M. J., Ramos, R. C., Duarte, J. L., Tura, B. R., Albuquerque, E. M., & Jesús, N. R. (2001) · Lupus · doi:10.1191/096120301678646137 · Cited by 398
Frequency of lupus flare in pregnancy: The hopkins lupus pregnancy center experience
Petri, M., Howard, D., & Repke, J. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780341210 · Cited by 390
Self-citationFessler, B. J., Alarcón, G. S., McGwin, G., Roseman, J., Bastian, H. M., Friedman, A. W., Baethge, B. A., Vilá, L., Reveille, J. D., & for the LUMINA Study Group (2005) · Arthritis & Rheumatism · doi:10.1002/art.21039 · Cited by 377
Recommendations on screening for chloroquine and hydroxychloroquine retinopathy
Marmor, M. F., Carr, R. E., Easterbrook, M., Farjo, A. A., & Mieler, W. F. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01168-5 · Cited by 371
Petri, M., Genovese, M., Engle, E., & Hochberg, M. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340802 · Cited by 340
Self-citationCostedoat‐Chalumeau, N., Amoura, Z., Duhaut, P., Huong, D. L. T., Sebbough, D., Wechsler, B., Vauthier, D., Denjoy, I., Lupoglazoff, J., & Piette, J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11304 · Cited by 314
A Long-Term Study of Hydroxychloroquine Withdrawal on Exacerbations in Systemic Lupus Erythematosus
The Canadian Hydroxychloroquine Study Group, Tsakonas, E., Joseph, L., Esdaile, J. M., Choquette, D., Senécal, J.-L., Cividino, A., Danoff, D., Osterland, C. K., Yeadon, C., et al. (1998) · Lupus · doi:10.1191/096120398678919778 · Cited by 293
Bioavailability of hydroxychloroquine tablets in healthy volunteers.
Tett, S., Cutler, D., Day, R., & Brown, K. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03439.x · Cited by 269
Validity and reliability of lupus activity measures in the routine clinic setting.
Petri, M., Hellmann, D. B., & Hochberg, M. C. (1992) · PubMed · Cited by 204
Self-citationAssessing disease activity in SLE patients during pregnancy
Buyon, J. P., Kalunian, K. C., Ramsey-Goldman, R., Petri, M. A., Lockshin, M. D., Ruiz-Irastorza, G., & Khamashta, M. (1999) · Lupus · doi:10.1191/096120399680411272 · Cited by 191
Self-citationEarly Risk Factors for Pregnancy Loss in Lupus
Clowse, M. E. B., Magder, L. S., Witter, F., & Petri, M. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000194205.95870.86 · Cited by 171
Self-citationFetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort.
Petri, M., & Allbritton, J. I. (1993) · PubMed · Cited by 169
Self-citationCostedoat-Chalumeau, N., Amoura, Z., Huong, D. L. T., Lechat, P., & Piette, J.-C. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.11.009 · Cited by 162
Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases.
Buchanan, N. M., Toubi, E., Khamashta, M. A., Lima, F., Kerslake, S., & Hughes, G. R. (1996) · Annals of the Rheumatic Diseases · doi:10.1136/ard.55.7.486 · Cited by 161
Follow-Up of Infants Exposed to Hydroxychloroquine Given to Mothers during Pregnancy and Lactation
Motta, M., Tincani, A., Faden, D., Zinzini, E., Lojacono, A., Marchesi, A., Frassi, M., Rebaioli, C. B., Zatti, S., & Chirico, G. (2004) · Journal of Perinatology · doi:10.1038/sj.jp.7211208 · Cited by 155
Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases
Klinger, G., Morad, Y., Westall, C. A., Laskin, C. A., Spitzer, K. A., Koren, G., Ito, S., & Buncic, R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06004-4 · Cited by 148
Pregnancy Outcome Following First Trimester Exposure to Chloroquine
Levy, M., Buskila, D., Gladman, D. D., Urowitz, M. B., & Koren, G. (1991) · American Journal of Perinatology · doi:10.1055/s-2007-999371 · Cited by 120
Hydroxychloroquine in pregnant patients with systemic lupus erythematosus.
Parke, A. L., & West, B. (1996) · PubMed · Cited by 107
Review of ACR renal criteria in systemic lupus erythematosus
Dooley, M. A., Aranow, C. B., & Ginzler, E. M. (2004) · Lupus · doi:10.1191/0961203304lu2023oa · Cited by 94
Pregnancy outcome and family size in systemic lupus erythematosus: a case-control study
Hardy, C., Palmer, B., Morton, S. J., Muir, K. R., & Powell, R. J. (1999) · Lara D. Veeken · doi:10.1093/rheumatology/38.6.559 · Cited by 64
Antimalarial agents in pregnancy
Motta, M., Tincani, A., Faden, D., Zinzini, E., & Chirico, G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07643-2 · Cited by 53
CLASSIFICATION CRITERIA FOR ANTIPHOSPHOLIPID SYNDROME
Wilson, W. A. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70216-7 · Cited by 41
Ducharme, J., Fieger, H., Ducharme, M., et al. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05768.x · Cited by 39
Hydroxychloroquine: past, present, future
Petri, M. (1998) · Lupus · doi:10.1191/096120398678919886 · Cited by 36
Self-citation
Cited by
Hahn, B. H., McMahon, M. A., Wilkinson, A., Wallace, W. D., Daikh, D. I., FitzGerald, J. D., Karpouzas, G. A., Merrill, J. T., Wallace, D. J., Yazdany, J., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21664 · Cited by 1,463
Götestam Skorpen, C., Hoeltzenbein, M., Tincani, A., Fischer-Betz, R., Elefant, E., Chambers, C., da Silva, J., Nelson-Piercy, C., Cetin, I., Costedoat-Chalumeau, N., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208840 · Cited by 1,068
Bertsias, G. K., Tektonidou, M., Amoura, Z., Aringer, M., Bajema, I., Berden, J. H. M., Boletis, J., Cervera, R., Dörner, T., Doria, A., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201940 · Cited by 1,007
Ruiz-Irastorza, G., Ramos-Casals, M., Brito-Zeron, P., & Khamashta, M. A. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101766 · Cited by 978
Andreoli, L., Bertsias, G. K., Agmon-Levin, N., Brown, S., Cervera, R., Costedoat-Chalumeau, N., Doria, A., Fischer-Betz, R., Forger, F., Moraes-Fontes, M. F., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209770 · Cited by 945
Metadata
- Authors
- Clowse, M. E. B., Magder, L., Witter, F., & Petri, M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2006-10-30
- Volume
- 54
- Issue
- 11
- Pages
- 3640-3647
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2019151860
- Cited by
- 529
- References
- 31
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.